Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookBaseline Assessment of the Nigerian Pharmaceutical Sector (WHO; 2002; 62 pages)
View the documentAcknowledgements
View the documentList of abbreviations
View the documentExecutive summary
Open this folder and view contentsIntroduction
View the documentTHE HEALTH STATUS OF NIGERIANS
View the documentUnder-Five Morbidity and Mortality Rates
Open this folder and view contentsBASIC HEALTH INDICATORS
View the documentStructure of the health system in Nigeria
close this folderDRUG SECTOR ORGANISATION
View the documentThe National Drug Policy
View the documentEssential Drugs List (EDL)
View the documentLegislation
View the documentMedicine financing
View the documentPharmaceutical Research and Production
View the documentRational Use of Medicines
View the documentHuman Resources
Open this folder and view contentsINTRODUCTION TO THE STUDY
Open this folder and view contentsSTUDY DESIGN AND METHODOLOGY
Open this folder and view contentsRESULTS AND ANALYSIS ACCESS
Open this folder and view contentsQUALITY AND SAFETY
Open this folder and view contentsINTERPRETATION OF RESULTS
Open this folder and view contentsCONCLUSIONS AND RECOMMENDED INTERVENTIONS
Open this folder and view contentsANNEX 1
Open this folder and view contentsANNEX 2
 

The National Drug Policy

The National Drug Policy was first published in 1990 with the main goals of making available at all times and in all sectors of the health care system, adequate supplies of drugs which are effective, affordable, safe and of good quality. The policy also aimed at improving the quality of health care through the rational use of drugs.

After about 13 years, the policy appears to have made little impact on the pharmaceutical sector due largely to the absence of an implementation plan, budget and timelines. These would have paved the way for a systematic translation of the policy into tangible improvements in the sector. Absence of monitoring and evaluation may also have contributed to the poor results recorded.

However, the policy is in the process of being revised. Efforts are being made to improve on the formulation process and to include an implementation plan. Wide dissemination of the revised document is planned in order to enlist the support and commitment of stakeholders and to also ensure systematic implementation of the policy.

One of the strategies employed, to ensure successful implementation and sustainability of the revised policy, is to include aspects of the policy in the curriculum of pharmacy and medical schools. The capacity of trainers at both undergraduate and graduate levels also needs to be strengthened.

A national policy on traditional medicines has also been formulated as a separate document and awaits adoption.

to previous sectionto next section

Please provide your feedback English  |  French